Previous close | 13.34 |
Open | 13.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 12.59 - 13.55 |
52-week range | 12.59 - 30.38 |
Volume | |
Avg. volume | 19,437 |
Market cap | 9.659M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PURCHASE, NY, April 25, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the three months ended March 31, 2024 (“First Quarter 2024”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2023 (“First Quarter 2023”). Financial and Operational Highlights for First Quarter 2024 First Quarter 2024 revenue grows 3% year-over-year to $646.1 millionFirst Quar
PURCHASE, NY, April 15, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its first quarter 2024 results, previously scheduled for 4:30 p.m. E.T. on April 25, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants,
PURCHASE, NY, April 12, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2024 results on Thursday, April 25, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For